What are the signs and symptoms of plasma leakage in a patient with dengue fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Plasma Leakage in Dengue

Plasma leakage in dengue manifests through specific warning signs that require immediate recognition: persistent vomiting, abdominal pain or tenderness, clinical fluid accumulation (pleural effusion, ascites), mucosal bleeding, lethargy or restlessness, hepatomegaly (>2 cm), and rising hematocrit with concurrent thrombocytopenia. 1

Clinical Warning Signs

The critical indicators of plasma leakage typically appear around days 3-7 of illness, coinciding with defervescence (when fever breaks): 1

  • Persistent vomiting - inability to tolerate oral fluids, strongly associated with progression to severe dengue 1, 2
  • Abdominal pain or tenderness - particularly right upper quadrant pain due to liver involvement, with pooled prevalence of 3.6% overall 1, 3, 2
  • Lethargy or restlessness - indicating potential progression to shock 1, 2
  • Mucosal bleeding - including epistaxis, gum bleeding, and gastrointestinal bleeding 1, 2
  • Hepatomegaly >2 cm - palpable liver enlargement 1, 2

Laboratory and Imaging Evidence

Hematological changes:

  • Rising hematocrit (>20% increase from baseline) with concurrent thrombocytopenia - the hallmark laboratory finding of plasma leakage 1, 4
  • Severe thrombocytopenia (<20 × 10⁹/L) - develops in 57% of patients with plasma leakage 3

Ultrasonographic findings (often detectable before hematocrit changes): 5, 6

  • Pleural effusion - most common sign, detected in 62% of dengue hemorrhagic fever cases one day after defervescence 6
  • Gallbladder wall thickening - detected in 43% of cases, resolves more rapidly than pleural effusion 6, 7, 2
  • Ascites - detected in 52% of cases 6, 2
  • Pericardial effusion - less common but significant 5

Clinical Fluid Accumulation

Physical examination findings indicating plasma leakage: 1

  • Detectable pleural effusion on chest examination
  • Ascites on abdominal examination
  • Clinical signs of third-spacing

Hemodynamic Manifestations

Signs of progression to dengue shock syndrome: 1

  • Narrow pulse pressure ≤20 mmHg - earlier and more sensitive indicator than absolute hypotension 1
  • Systolic blood pressure <90 mmHg for >30 minutes 1
  • Signs of end-organ hypoperfusion:
    • Cold, clammy extremities or livedo reticularis 1
    • Capillary refill time ≥3 seconds 1
    • Elevated lactate >2 mmol/L 1

Critical Timing Considerations

Ultrasound can detect plasma leakage starting from 2 days before defervescence and sometimes within 3 days after fever onset - significantly earlier than hematocrit changes. 6 In one study, 84.2% of patients with subclinical plasma leakage detected by ultrasound at initial presentation progressed to dengue with warning signs. 5

Important Clinical Pitfalls

  • Minimal agreement exists between hematocrit levels and ultrasound detection of plasma leakage (kappa 0.135), meaning hematocrit alone may miss early plasma leakage 5
  • Ultrasound detected plasma leakage in 12 of 17 dengue hemorrhagic fever cases who did not meet criteria for significant hemoconcentration 6
  • Plasma leakage typically lasts only 48 hours and resolves spontaneously, but severity varies greatly among patients 7
  • The size of pleural effusions, ascites, and gallbladder wall thickness in dengue hemorrhagic fever grades I and II are smaller than grade III patients 6

Risk Stratification

Patients presenting with abdominal pain and cough are significantly more likely to develop plasma leakage syndrome and should be monitored closely. 3 With appropriate recognition and management of these warning signs, mortality can be reduced to <0.5%. 1

References

Guideline

Danger Signs of Dengue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Predictors of severe manifestations in a cohort of adult dengue patients.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.